202 results on '"Earnest, David L."'
Search Results
2. Dietary Fiber or Piroxicam as Potential Cancer Prevention Agents: Effects on Rectal Epithelial Cell Proliferation in Humans at Increased Risk of Colon Cancer
3. Long-Term Tegaserod Treatment for Dysmotility-like Functional Dyspepsia: Results of Two Identical 1-year Cohort Studies
4. The Incidence of Abdominal and Pelvic Surgery Among Patients with Irritable Bowel Syndrome
5. Patchy field defects of apoptosis resistance and dedifferentiation in flat mucosa of colon resections from colon cancer patients
6. MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness
7. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas
8. Tegaserod and the Risk of Cardiovascular Ischemic Events: An Observational Cohort Study
9. Omeprazole-induced slowing of gastrointestinal transit in mice can be countered with tegaserod
10. Tegaserod Treatment for Dysmotility-Like Functional Dyspepsia: Results of Two Randomized, Controlled Trials
11. Safety, Tolerability, and Efficacy of Tegaserod over 13 Months in Patients with Chronic Constipation: CME
12. Tegaserod Does not Alter Fasting or Meal-Induced Biliary Tract Motility
13. Physical Activity, Body Mass Index, and Prostaglandin E2 Levels in Rectal Mucosa
14. The Zelnorm epidemiologic study (ZEST): a cohort study evaluating incidence of abdominal and pelvic surgery related to tegaserod treatment
15. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis
16. Simultaneous quantitation of fatty acids, sterols and bile acids in human stool by capillary gas–liquid chromatography
17. Modulation of Kupffer cell and peripheral blood monocyte activity byin vivo treatment of rats with all-trans-retinol
18. Whose guidelines should you use?
19. Guidelines for Training in Gallstone Lithotripsy
20. Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome
21. The Duty of Arbitrators to Delimitate between Jurisdiction and Admissibility in Investor-State Arbitration: A Developed Consensus or an Enduring Lacuna?
22. A convenient synthesis of dinorbile acids: : Oxidative hydrolysis of norbile acid nitriles☆
23. Protective role of wheat bran fiber: data from marker trials
24. Progress report: the Arizona phase III study of the effect of wheat bran fiber on recurrence of adenomatous colon polyps
25. Treatment advances in acid secretory disorders: the promise of rapid symptom relief with disease resolution
26. Esophageal hypersensitivity may be a major cause of heartburn
27. Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint
28. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.
29. Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome.
30. Idiopathic cecal ulcer: Diagnosis by colonoscopy followed by nonoperative management
31. Unusual contrast accumulations seen during percutaneous cholangiography
32. Rifaximin and eluxadoline — newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
33. Su1379 Using the FDA Composite Endpoint for IBS-D to Compare Treatment Effectiveness of Existing and Investigational Therapeutic Options
34. Long-Term Tegaserod Treatment for Dysmotility-like Functional Dyspepsia: Results of Two Identical 1-year Cohort Studies
35. Geographic information systems can enhance economic development efforts at local and state levels
36. Cholescintigraphy in the evaluation of jaundice
37. Modulation of Kupffer cell and peripheral blood monocyte activity by in vivo treatment of rats with all-trans-retinol
38. Protective Effect of Tegaserod Against Indomethacin-Induced Gastric Injury in the Rat
39. Results of a Phase I Multiple-Dose Clinical Study of Ursodeoxycholic Acid
40. Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms
41. Statement on outpatient percutaneous liver biopsy
42. The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts
43. Antibiotic treatment prevents increased kupffer cell intracellular superoxide induced by acute alcohol ingestion
44. Suppression of cyclooxygenase does not have an early effect on rectal epithelial cell proliferation
45. A single alcohol binge significantly lowers the threshold for liver injury by acetaminophen and ischemia
46. Heartburn/stomach symptoms during chronic proton pump inhibitor therapy: Evidence for occasional symptom breakthrough
47. Immunological changes in retrovirus-infected mice.
48. Dietary ethanol modulates immune responses, and alter resistance to Streptococcus pneumoniae in LP-BM5 retrovirus infected mice.
49. Retinol activation of Kupffer cells: A mechanism for potentiation of chemically-induced liver injury
50. GASTRIC XANTHELASMA IN A PATIENT AFTER PARTIAL GASTRECTOMY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.